With the recent inking of a Memorandum of Understanding (“MOU”) between the Centers for Medicare & Medicaid Services (CMS) and the Food and Drug Administration (FDA) concerning sharing information and expertise, these two influential agencies continue to inch their way toward a concurrent review process for marketing approval and Medicare coverage.

Seminar Information
Seminar Date:
August 30, 2011
Synchronizing Regulatory and Reimbursement Review -- What’s Next from CMS and the FDA
Individual topic purchase: Selected
Online Materials
LES Member Price:$0.00
Non-Member Price:$0.00